Mark Capone is currently the Board Member and CEO of Precision Medicine Advisors, a consulting firm specializing in precision medicine. They have held various leadership roles, including CEO and President at Myriad Genetics, and have served on multiple boards for organizations such as Penn State University and Eli Lilly. Mark's educational background includes a BS in Chemical Engineering from Penn State University and dual master's degrees in Chemical Engineering and Management from the Massachusetts Institute of Technology. Additionally, they are actively involved as a strategic advisor for several biotech companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices